ATE453401T1 - Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung - Google Patents

Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung

Info

Publication number
ATE453401T1
ATE453401T1 AT01988597T AT01988597T ATE453401T1 AT E453401 T1 ATE453401 T1 AT E453401T1 AT 01988597 T AT01988597 T AT 01988597T AT 01988597 T AT01988597 T AT 01988597T AT E453401 T1 ATE453401 T1 AT E453401T1
Authority
AT
Austria
Prior art keywords
gene
hemophilia
therapy
genetherapeutic
treatment
Prior art date
Application number
AT01988597T
Other languages
English (en)
Inventor
Jiahui Xia
Original Assignee
Jiahui Xia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiahui Xia filed Critical Jiahui Xia
Application granted granted Critical
Publication of ATE453401T1 publication Critical patent/ATE453401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01988597T 2000-08-30 2001-08-29 Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung ATE453401T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00113652 2000-08-30
CNB011028300A CN1148228C (zh) 2000-08-30 2001-01-19 治疗血友病b的基因药物及其制备方法
PCT/CN2001/001291 WO2002034296A1 (fr) 2000-08-30 2001-08-29 Nouvel agent de therapie genique permettant de traiter l'hemophilie b et son procede de preparation

Publications (1)

Publication Number Publication Date
ATE453401T1 true ATE453401T1 (de) 2010-01-15

Family

ID=25739400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01988597T ATE453401T1 (de) 2000-08-30 2001-08-29 Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung

Country Status (8)

Country Link
US (1) US7361639B2 (de)
EP (1) EP1316319B1 (de)
JP (1) JP2004512313A (de)
CN (1) CN1148228C (de)
AT (1) ATE453401T1 (de)
AU (1) AU2002223402A1 (de)
DE (1) DE60140950D1 (de)
WO (1) WO2002034296A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000268170A1 (en) * 2000-09-04 2002-03-22 Hunan Royal Biotech A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
CN1880458B (zh) * 2005-06-15 2010-04-28 中国医学科学院基础医学研究所 人β-珠蛋白基因簇的人源染色体打靶载体及其应用
US8980382B2 (en) * 2009-12-02 2015-03-17 Applied Materials, Inc. Oxygen-doping for non-carbon radical-component CVD films
KR20160135729A (ko) 2014-03-21 2016-11-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 뉴클레아제 없는 게놈 편집
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
NZ759034A (en) 2017-05-22 2023-07-28 Takeda Pharmaceuticals Co Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia b
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710288B1 (de) * 1993-06-10 2006-04-05 Genetic Therapy, Inc. Adenovirale vektoren für die behandlung der hämophilie
AU6468199A (en) 1998-09-23 2000-04-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method to treat haemophilia by (in vivo) gene therapy with retroviral vectors

Also Published As

Publication number Publication date
JP2004512313A (ja) 2004-04-22
EP1316319A1 (de) 2003-06-04
EP1316319B1 (de) 2009-12-30
AU2002223402A1 (en) 2002-05-06
CN1302664A (zh) 2001-07-11
US7361639B2 (en) 2008-04-22
WO2002034296A1 (fr) 2002-05-02
CN1148228C (zh) 2004-05-05
US20040038919A1 (en) 2004-02-26
EP1316319A4 (de) 2008-08-06
DE60140950D1 (de) 2010-02-11

Similar Documents

Publication Publication Date Title
DE3680368D1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
HUP9901254A2 (hu) Nemdendrites szerkezetű gerincet alkotó peptid hordozó
ATE510558T1 (de) Verwendung von biologisch aktivem hiv-1 tat, fragmenten oder derivaten davon, zur bestimmung und/oder aktivierung von antigen-präsentierenden zellen, und/oder zur abgabe von cargo-molekülen für impfung und/oder für behandlung von anderen erkrankungen
BR9814276A (pt) Antìgenos de superfìcie
HUP0203056A1 (hu) Vakcinakészítmény
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
DE60238486D1 (de) Verfahren zur genetischen modifikation hämatopoetischer vorläuferzellen und verwendungen der modifizierten zellen
DK0910647T3 (da) Human DNase i hyperaktive varianter
HUP0000088A2 (hu) N-Szubsztituált azaheterociklusos vegyületek, eljárás előállításukra, valamint ezeket a vegyületeket tartalmazó gyógyszerkészítmények
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
EA200700656A1 (ru) Стабильные жидкие композиции плазмидной днк
DE60118743D1 (de) Methode zur behandlung und prävention von ansteckenden krankheiten
CY1112867T1 (el) Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE285239T1 (de) Dna enthaltende impfstoffen
ATE453401T1 (de) Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
DE50010519D1 (de) Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
ATE277625T1 (de) Pharmazeutische zusammensetzung aus spinnengiften sowie deren herstellung und verwendung zur behandlung von tumorerkrankungen
ATE285773T1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
SE9700244D0 (sv) Novel antibacterial protein
ATE375800T1 (de) Anti-hiv und anti-tumor lysozympeptide sowie fragmente
ATE278011T1 (de) Human dnase ii
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties